# Peri-Operative Testosterone Administration in Primary Total Hip Arthroplasty

> **NCT06608914** · PHASE4 · NOT_YET_RECRUITING · sponsor: **American Hip Institute** · enrollment: 60 (estimated)

## Conditions studied

- Osteoarthritis, Hip

## Interventions

- **DRUG:** Nandrolone decanoate
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06608914
- **Lead sponsor:** American Hip Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06608914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06608914, "Peri-Operative Testosterone Administration in Primary Total Hip Arthroplasty". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06608914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*